| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible plate-based multiplexing. The new assay delivers cost-effective, highly scalable single cell analysis, empowering researchers to explore a broad range of studies - from high cell-number applications like functional genomics CRISPR screens to high-sample number applications like FFPE-based translational studies. With this assay, scientists can uncover new insights at scale and drive discoveries that were previously out of reach.
Posted In: TXG
